Several well-known predisposition genetic variants including BRCA2 and CHEK2 have been found to have strong association with lung cancer risk10 and rare pathogenic germline mutations in genes of Fanconi anemia pathway also contribute to the risk of squamous lung cancers11. This evidence concerns the gene CHEK2 and lung cancer.